Visual contrast threshold at 15 Hz is able to confirm visual snow syndrome in individual patients (S20.005)
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: To confirm the presence of visual snow syndrome (VS) in the individual patient. We tested the hypothesis that patients with VS have an increased threshold for detecting visual contrasts.
Background: Patients with VS suffer from a continuous TV snow-like visual disturbance in the entire visual field that might reduce the contrast perceived. Currently, the only objective measure is hypermetabolism of the lingual gyrus found at the group level. In clinical practice, however, individual patients present with subjective symptoms, and objective measures are lacking to confirm the diagnosis.
Design/Methods: Twenty patients with VS were compared to 20 age-, gender-, migraine- and aura-matched controls. Subjects were randomly presented vertically left or right tilted bars flickering at six different frequencies (15Hz, 20Hz, 25Hz, 30Hz, 35Hz, 40Hz). The contrast threshold was measured in a two-alternative adaptive forced-choice procedure (QUEST) for the discrimination between the two image orientations. The threshold was defined as the log10 (Michelson-Contrast) necessary to achieve the correct response in 75% of the cases.
Results: The 75% contrast threshold at 15 Hz was significantly higher in VS patients compared to controls (0.601 Wilks-Lambda p=0.007; −1.94±0.13 vs. −2.26±0.37, T=−3.71, p=0.001, MANOVA). The AUC for the ROC curve of 75% contrast threshold at 15 Hz was 0.73±0.09. A contrast threshold of −2,00 is able to support the diagnosis of VS in an individual patient with a sensitivity of 80% and a specificity of 70%.
Conclusions: The visual 75% contrast threshold measured at 15 Hz is the first technical test that might be able to confirm the hitherto purely subjective and history-driven diagnosis of VS in an individual patient.
Disclosure: Dr. Eren has nothing to disclose. Dr. Eggert has nothing to disclose. Dr. Ruscheweyh has nothing to disclose. Dr. Straube has nothing to disclose. Dr. Schankin has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novartis Pharmaceuticals, Almirall, Eli Lilly, and Allergan.
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan
Related Articles
- No related articles found.